Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration. (2023)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2023.112950
PubMed Identifier: 37441939
Publication URI: http://europepmc.org/abstract/MED/37441939
Type: Journal Article/Review
Volume: 190
Parent Publication: European journal of cancer (Oxford, England : 1990)
ISSN: 0959-8049